Literature DB >> 29439332

Early and Selective Activation and Subsequent Alterations to the Unfolded Protein Response in Down Syndrome Mouse Models.

Chiara Lanzillotta1,2, Antonella Tramutola1, Shelby Meier2, Frederick Schmitt2,3,4, Eugenio Barone1,5, Marzia Perluigi1, Fabio Di Domenico1, Jose F Abisambra2,6,3.   

Abstract

Down syndrome (DS) is the most common chromosomal disorder and the leading genetic cause of intellectual disability in humans, which results from the triplication of chromosome 21. DS individuals have an increased risk of developing Alzheimer's disease (AD)-like pathology and dementia by the age of 40 due to the triplication of several genes involved in the formation of amyloid plaques and tau tangles. Further, DS and AD are characterized by the aberrant accumulation of unfolded/misfolded proteins resulting from over-burdened protein quality control systems. The accumulation of misfolded proteins in the endoplasmic reticulum (ER) triggers a cellular stress response called the unfolded protein response (UPR). Long-term activation of the UPR mediates neuronal dysfunction in AD. We hypothesized that the UPR is impacted in a mouse model of DS. To test this, we performed gene and protein expression analysis of ER stress markers in the Ts65Dn mouse model of DS at 3, 9, and 18 months. We identified activation of the PERK pathway in Ts65Dn DS mice at 3 months of age compared to euploid controls. We also determined that the early and overt UPR activation decreased with age, the UPR signal was significantly reduced by 18 months. Our data suggest that UPR activation in DS mouse models occurs early before consistent brain neurodegeneration and might be an essential contributor to dys-proteostasis.

Entities:  

Keywords:  Down syndrome; PERK; Ts65Dn; eif2 alpha; unfolded protein response

Mesh:

Substances:

Year:  2018        PMID: 29439332      PMCID: PMC5988365          DOI: 10.3233/JAD-170617

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  42 in total

Review 1.  Genetic and host factors for dementia in Down's syndrome.

Authors:  Nicole Schupf; Gertrude H Sergievsky
Journal:  Br J Psychiatry       Date:  2002-05       Impact factor: 9.319

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.

Authors:  Laura G Reinholdt; Yueming Ding; Griffith J Gilbert; Griffith T Gilbert; Anne Czechanski; Jeffrey P Solzak; Randall J Roper; Mark T Johnson; Leah Rae Donahue; Cathleen Lutz; Muriel T Davisson
Journal:  Mamm Genome       Date:  2011-09-28       Impact factor: 2.957

Review 4.  Functional and morphological impact of ER stress on mitochondria.

Authors:  Kayleen Vannuvel; Patricia Renard; Martine Raes; Thierry Arnould
Journal:  J Cell Physiol       Date:  2013-09       Impact factor: 6.384

5.  Impaired proteasome function in Alzheimer's disease.

Authors:  J N Keller; K B Hanni; W R Markesbery
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

6.  The unfolded protein response is activated in Alzheimer's disease.

Authors:  J J M Hoozemans; R Veerhuis; E S Van Haastert; J M Rozemuller; F Baas; P Eikelenboom; W Scheper
Journal:  Acta Neuropathol       Date:  2005-06-23       Impact factor: 17.088

Review 7.  Beta-amyloid, oxidative stress and down syndrome.

Authors:  Ira T Lott; Elizabeth Head; Eric Doran; Jorge Busciglio
Journal:  Curr Alzheimer Res       Date:  2006-12       Impact factor: 3.498

Review 8.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

9.  Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation.

Authors:  Jose F Abisambra; Umesh K Jinwal; Laura J Blair; John C O'Leary; Qingyou Li; Sarah Brady; Li Wang; Chantal E Guidi; Bo Zhang; Bryce A Nordhues; Matthew Cockman; Amirthaa Suntharalingham; Pengfei Li; Ying Jin; Christopher A Atkins; Chad A Dickey
Journal:  J Neurosci       Date:  2013-05-29       Impact factor: 6.167

10.  The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease.

Authors:  Lauren D Stutzbach; Sharon X Xie; Adam C Naj; Roger Albin; Sid Gilman; Virginia M Y Lee; John Q Trojanowski; Bernie Devlin; Gerard D Schellenberg
Journal:  Acta Neuropathol Commun       Date:  2013-07-06       Impact factor: 7.801

View more
  12 in total

1.  Activation of the ISR mediates the behavioral and neurophysiological abnormalities in Down syndrome.

Authors:  Ping Jun Zhu; Sanjeev Khatiwada; Ya Cui; Lucas C Reineke; Sean W Dooling; Jean J Kim; Wei Li; Peter Walter; Mauro Costa-Mattioli
Journal:  Science       Date:  2019-11-15       Impact factor: 47.728

Review 2.  Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches.

Authors:  Clíona Farrell; Paige Mumford; Frances K Wiseman
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

Review 3.  Tau-mediated dysregulation of RNA: Evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies.

Authors:  Shon A Koren; Sara Galvis-Escobar; Jose F Abisambra
Journal:  Neurobiol Dis       Date:  2020-05-12       Impact factor: 5.996

4.  Multiple Herpes Simplex Virus-1 (HSV-1) Reactivations Induce Protein Oxidative Damage in Mouse Brain: Novel Mechanisms for Alzheimer's Disease Progression.

Authors:  Virginia Protto; Antonella Tramutola; Marco Fabiani; Maria Elena Marcocci; Giorgia Napoletani; Federica Iavarone; Federica Vincenzoni; Massimo Castagnola; Marzia Perluigi; Fabio Di Domenico; Giovanna De Chiara; Anna Teresa Palamara
Journal:  Microorganisms       Date:  2020-06-29

5.  Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome.

Authors:  Antonella Tramutola; Chiara Lanzillotta; Eugenio Barone; Andrea Arena; Ilaria Zuliani; Luciana Mosca; Carla Blarzino; D Allan Butterfield; Marzia Perluigi; Fabio Di Domenico
Journal:  Transl Neurodegener       Date:  2018-11-06       Impact factor: 8.014

6.  Proteomics Study of Peripheral Blood Mononuclear Cells in Down Syndrome Children.

Authors:  Chiara Lanzillotta; Viviana Greco; Diletta Valentini; Alberto Villani; Valentina Folgiero; Matteo Caforio; Franco Locatelli; Sara Pagnotta; Eugenio Barone; Andrea Urbani; Fabio Di Domenico; Marzia Perluigi
Journal:  Antioxidants (Basel)       Date:  2020-11-11

Review 7.  Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules.

Authors:  Chiara Lanzillotta; Fabio Di Domenico
Journal:  Biomolecules       Date:  2021-02-11

Review 8.  Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.

Authors:  Mara Dierssen; Marta Fructuoso; María Martínez de Lagrán; Marzia Perluigi; Eugenio Barone
Journal:  Front Neurosci       Date:  2020-07-08       Impact factor: 4.677

9.  SNARE proteins rescue impaired autophagic flux in Down syndrome.

Authors:  Stefanos Aivazidis; Abhilasha Jain; Abhishek K Rauniyar; Colin C Anderson; John O Marentette; David J Orlicky; Kristofer S Fritz; Peter S Harris; David Siegel; Kenneth N Maclean; James R Roede
Journal:  PLoS One       Date:  2019-11-12       Impact factor: 3.240

10.  Activation of Mitochondrial Unfolded Protein Response in SHSY5Y Expressing APP Cells and APP/PS1 Mice.

Authors:  Yang Shen; Mao Ding; Zhaohong Xie; Xiangtian Liu; Hui Yang; Suqin Jin; Shunliang Xu; Zhengyu Zhu; Yun Wang; Dewei Wang; Linlin Xu; Xiaoyan Zhou; Ping Wang; Jianzhong Bi
Journal:  Front Cell Neurosci       Date:  2020-01-08       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.